ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,611Medicare Part D Prescriptions Filled, Including Refills

Rank: 252 out of 2680

$547K Total Retail Price of All Prescriptions

Rank: 289 out of 2680

445 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 445 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 445 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 6,391 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 349 253 1 7
LEVOTHYROXINE SODIUM 345 264 2 4
SIMVASTATIN 301 214 3 1
LISINOPRIL 283 243 4 5
METOPROLOL TARTRATE 264 213 5 8
CITALOPRAM HBR 192 146 6 22
LANTUS 181 89 7 70
DONEPEZIL HCL 174 172 8 28
SERTRALINE HCL 170 153 9 23
OMEPRAZOLE 157 87 10 2
WARFARIN SODIUM 139 100 11 12
ALBUTEROL SULFATE 136 119 12 97
AMLODIPINE BESYLATE 132 104 13 3
NAMENDA 124 114 14 43
GABAPENTIN 102 35 15 21
PREDNISONE 100 77 16 45
POTASSIUM CHLORIDE 96 55 17 29
SPIRIVA 91 76 18 36
CARVEDILOL 89 64 19 27
IPRATROPIUM BROMIDE 88 87 20 157
KLOR-CON M20 86 62 21 101
TRAZODONE HCL 86 35 21 60
RISPERIDONE 85 55 23 67
CYMBALTA 82 43 24 56
ATENOLOL 81 81 25 14
ADVAIR DISKUS 81 59 25 32
HYDROCODONE-ACETAMINOPHEN 78 53 S3 27 13
CLOPIDOGREL 73 56 28 30
MIRTAZAPINE 71 71 29 48
RANITIDINE HCL 70 70 30 35
ATORVASTATIN CALCIUM 66 65 31 10
HYDROCHLOROTHIAZIDE 64 58 32 9
SYNTHROID 61 47 33 39
ZOLPIDEM TARTRATE 61 51 33 17
TAMSULOSIN HCL 61 51 33 25
PANTOPRAZOLE SODIUM 60 50 36 44
TRAMADOL HCL 60 49 36 33
ISOSORBIDE MONONITRATE ER 59 50 38 57
PRAVASTATIN SODIUM 58 41 39 16
KLOR-CON M10 56 49 40 185
QUETIAPINE FUMARATE 55 40 41 72
LOSARTAN POTASSIUM 54 46 42 18
METOPROLOL SUCCINATE 54 42 42 11
METFORMIN HCL 53 32 44 6
CARBIDOPA-LEVODOPA 52 42 45 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 8, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.